Crossmark

Mixed-methods approach to evaluate an mHealth intervention to increase adherence to triage of human papillomavirus-positive women who have performed self-collection (the ATICA study): study protocol for a hybrid type I cluster randomized effectiveness-implementation trial

Crossref DOI link: https://doi.org/10.1186/S13063-019-3229-3

Published Online: 2019-02-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Arrossi, Silvina

Paolino, Melisa

Orellana, Liliana

Thouyaret, Laura

Kohler, Racquel E.

Viswanath, Kasisomayajula
Funding

Funding for this research was provided by:

National Cancer Institute/NIH (R01CA218306)
License Information

Text and Data Mining valid from 2019-02-26

Version of Record valid from 2019-02-26
More Information

Article History

Received: 19 June 2018

Accepted: 29 January 2019

First Online: 26 February 2019

Ethics approval and consent to participate

: This protocol was approved by the CEMIC Institutional Review Board, the Ethics Research Committee of the Jujuy Ministry of Health, The Institutional Review Board of the Harvard T.H. Chan School of Public Health and the Deakin University Human Research Ethics Committee. The trial is registered in ClinicalTrials.gov (NCT03478397) and the Deakin University Human Ethics Research Committee (APP 2018–039). Women have to sign an informed consent before the study begins, as well as CHWs participating in the CHW survey. Anonymity of participants is guaranteed.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below